COVID-19

The findings could help in future vaccine prioritization strategies and therapeutic allocation policies for other pandemic.

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.

Proof-of-concept device will be able to detect SARS-CoV-2 within minutes.

The approval makes remdesivir the first and only approved antiviral treatment for patients across all stages of renal disease.

The effectiveness of influenza vaccines varies each season and is determined by the circulating influenza virus subtype(s) and the extent to which there is an antigenic match in the vaccines to the circulating virus subtypes.

A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.

Using artificial intelligence to sort and respond to patient queries could streamline processes and alleviate provider burnout.

Older adults are vulnerable to severe influenza-associated complications and risks, but influenza vaccines may be less effective in this population.

Pre-exposure prophylaxis of neutralizing SARS-CoV-2 monoclonal antibodies may be preventative against SARS-CoV-2 transmission, decreasing frequency of new infections and number of hospitalized patients who need antiviral therapies, thus lowering costs.

By empathizing with patients and creating an environment where patients feel comfortable and open to sharing, pharmacists can increase compliance and adherence.

The study also found significant evidence of outcomes disparities between minority populations and White populations.

OTC cases focus on recommendations for vaccination boosters and managing fever.

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Novavax announced the development of a protein-based monovalent XBB COVID-19 vaccine with the intention of it being manufactured and available for the fall vaccination campaign.

Investigators found that individuals who received metformin were approximately 40% less likely to develop long COVID than those who received a placebo.

Health care professionals can provide patients with tips on appropriate hand sanitizer use, as well as product recommendations.

In-person visits to receive oral therapy, outpatient infusions, and inpatient infusion for the treatment of hematologic neoplasms declined in the early months of the COVID-19 pandemic, while telemedicine use increased slightly in the same period but remained low overall.

Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.

It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.

There may be more than 200 symptoms associated with long COVID-19.

It’s imperative to redefine the future of pharmacy to help ensure a robust pipeline of future pharmacists and create a culture that helps ensure pharmacists live their purpose and passion.

Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.

Research shows receipt of medications for chronic conditions was relatively stable in the first 2 years of the pandemic from 2020 to 2021 across racial and ethnic groups.

Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.

Decentralization has already been shown to streamline clinical trials, but it also has the potential to improve the broader health care ecosystem.

With so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.

This marks the fourth drug, and first oral antiviral pill, approved by the FDA to treat adults with mild-to-moderate COVID-19.

EUA restriction for hospitalized patients was basis for lawsuit that advanced several arguments.

Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.